Comparison of Certolizumab Pegol Versus Adalimumab: 2 Year Efficacy and Safety Results from a Superiority, Investigator-Blind, Head-to-Head Study

被引：0

作者：

Fleischmann, Roy ^{[1
]}

Burmester, Gerd-Rudiger ^{[2
]}

Combe, Bernard ^{[3
]}

Curtis, Jeffrey R. ^{[4
]}

Hal, Stephen ^{[5
]}

Haraoui, Boulos ^{[6
]}

van Vollenhoven, Ronald ^{[7
]}

Cioffi, Christopher ^{[8
]}

Ecoffet, Cecile ^{[9
]}

Ionescu, Lucian ^{[9
]}

Gervitz, Leon ^{[10
]}

Peterson, Luke ^{[8
]}

Smolen, Josef ^{[11
,12
]}

机构：

[1] Univ Texas Southwestern Med Ctr Dallas, Metroplex Clin Res Ctr, Dallas, TX 75390 USA

[2] Charite Univ Med Berlin, Berlin, Germany

[3] Montpellier Univ Hosp, Montpellier, France

[4] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL USA

[5] Monash Univ, Cabrini Med Ctr, Melbourne, Vic, Australia

[6] Ctr Hosp Univ Montreal, Dept Med, Montreal, PQ, Canada

[7] Amsterdam Rheumatol & Immunol Ctr ARC, Amsterdam, Netherlands

[8] UCB Pharma, Raleigh, NC USA

[9] UCB Pharma, Brussels, Belgium

[10] UCB Pharma, RA Patient Value Mission, Brussels, Belgium

[11] Med Univ Vienna, Vienna, Austria

[12] Hietzing Hosp, Vienna, Austria

来源：

ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2987

引用

页数：3

共 50 条

[31] Safety and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Advanced Breast Cancer: A Head-to-Head Comparison of Margetuximab versus Trastuzumab
Zhang, Liyi
[J]. ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2021, 8 (04) : 349 - 351
[32] Antidepressant efficacy of agomelatine versus SSRI/SNRI: results from a pooled analysis of head-to-head studies without a placebo control
Kasper, Siegfried
Corruble, Emmanuelle
Hale, Anthony
Lemoine, Patrick
Montgomery, Stuart A.
Quera-Salva, Maria-Antonia
[J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2013, 28 (01) : 12 - 19
[33] Efficacy and Safety of Certolizumab Pegol Plus Methotrexate in Patients With Rheumatoid Arthritis: 3-Year Data From the RAPID 2 Study
Smolen, Josef
Van Vollenhoven, Ronald
Kavanaugh, Arthur
Fichtner, Andreas
Strand, Vibeke
Vencovsky, Jiri
Van der Heijde, Desiree
[J]. JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1152 - 1152
[34] EFFICACY AND SAFETY OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: 3-YEAR DATA FROM THE RAPID 2 STUDY
Smolen, Josef
van Vollenhoven, Ronald
Kavanaugh, Arthur
Fichtner, Andreas
Strand, Vibeke
Vencovsky, Jiri
van der Heijde, Desiree
[J]. RHEUMATOLOGY, 2011, 50 : 123 - 123
[35] A HEAD-TO-HEAD COMPARISON OF IXEKIZUMAB AND ADALIMUMAB IN BIOLOGIC-NAIVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 52-WEEK EFFICACY AND SAFETY OUTCOMES FROM A RANDOMIZED, OPEN-LABEL, BLINDED ASSESSOR STUDY
Smolen, Josef
Nash, Peter
Tahir, Hasan
Schulze-Koops, Hendrik
Li, Lingnan
Hojnik, Maja
Gellett, Amanda M.
Leage, Soyi Liu
Pillai, Sreekumar G.
Mease, Philip
[J]. INTERNAL MEDICINE JOURNAL, 2020, 50 : 17 - 17
[36] A Head-to-Head Comparison of Ixekizumab and Adalimumab in Biologic-Naive Patients with Active Psoriatic Arthritis: Efficacy and Safety Outcomes from a Randomized, Open-Label, Blinded Assessor Study Through 52 Weeks
Smolen, Josef
Nash, Peter
Tahir, Hasan
Schulze-Koops, Hendrik
Li, Lingnan
Hojnik, Maja
Gellett, Amanda
Liu-Leage, Soyi
Pillai, Sreekumar
Mease, Philip J.
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[37] A HEAD-TO-HEAD COMPARISON OF IXEKIZUMAB AND ADALIMUMAB IN BIOLOGIC-NAiVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 52-WEEK EFFICACY AND SAFETY OUTCOMES FROM A RANDOMIZED, OPEN-LABEL, BLINDED ASSESSOR STUDY
Chaudhury, Sukanya
Gellett, Amanda M.
Hojnik, Maja
Leage, Soyi Liu
Li, Lingnan
Mease, Philip
Nash, Peter
Pillai, Sreekumar G.
Schulze-Koops, Hendrik
Smolen, Josef
Tahir, Hasan
[J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 125 - 125
[38] A Head-to-Head Comparison of Ixekizumab and Adalimumab in Biologic-Naive Patients with Active Psoriatic Arthritis: 52-Week Efficacy and Safety Outcomes from a Randomized, Open-Label, Blinded Assessor study
Smolen, Josef
Nash, Peter
Tahir, Hasan
Schulze-Koops, Hendrik
Li, Lingnan
Hojnik, Maja
Gellett, Amanda
Liu-Leage, Soyi
Pillai, Sreekumar
Mease, Philip
Bessette, Louis
[J]. JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1042 - 1042
[39] Long-term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease: 7-year results from the PRECiSE 3 study
Sandborn, W. J.
Lee, S. D.
Randall, C.
Gutierrez, A.
Schwartz, D. A.
Ambarkhane, S.
Kayhan, C.
Pierre-Louis, B.
Schreiber, S.
Lichtenstein, G. R.
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (08) : 903 - 916
[40] Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial
Warren, R. B.
Lebwohl, M.
Sofen, H.
Piguet, V.
Augustin, M.
Brock, F.
Arendt, C.
Fierens, F.
Blauvelt, A.
[J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (12) : 2398 - 2408

← 1 2 3 4 5 →